These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15095259)

  • 21. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
    Horváth B; Hegyesi H; Nagy P; Falus A; Schaff Z
    Head Neck; 2005 Jul; 27(7):585-96. PubMed ID: 15887216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
    Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
    ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer.
    Figueiredo ML; Kim Y; St John MA; Wong DT
    Clin Cancer Res; 2005 May; 11(10):3939-48. PubMed ID: 15897596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
    Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
    Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
    Farnebo L; Jerhammar F; Vainikka L; Grénman R; Norberg-Spaak L; Roberg K
    Oncol Rep; 2008 Aug; 20(2):453-61. PubMed ID: 18636211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
    Kim SH; Lee SY; Park HR; Sung JM; Park AR; Kang S; Kim BG; Choi YP; Kim YB; Cho NH
    Cancer; 2011 May; 117(9):1864-73. PubMed ID: 21509763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.
    Lothaire P; de Azambuja E; Dequanter D; Lalami Y; Sotiriou C; Andry G; Castro G; Awada A
    Head Neck; 2006 Mar; 28(3):256-69. PubMed ID: 16284973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular signatures associated with clinical outcome in patients with high-risk head-and-neck squamous cell carcinoma treated by surgery and radiation.
    Giri U; Ashorn CL; Ramdas L; Stivers DN; Coombes K; El-Naggar AK; Ang KK; Story MD
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):670-7. PubMed ID: 16289374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.